Patient Resources

ALK Testing Resources

What is ALK Testing?

ALK stands for the anaplastic lymphoma kinase gene and rearrangement of this gene occurs in approximately 3-5% of non-small cell lung cancer (NSCLC). The following provides resources and information regarding ALK testing and is designed to help pathologists, laboratory scientists, and practicing physicians better understand the background, protocol, and the interpretation of results of ALK testing in patients.

IASLC Atlas of ALK Testing

Click here to launch interactive view (ENGLISH)

 

Now Available as a Mobile App!

 

The IASLC Atlas of ALK Testing in Lung Cancer app is a resource designed to help pathologists, laboratory scientists, and practicing physicians better understand various methods of anaplastic lymphoma kinase (ALK) testing and the interpretation of test results. This Atlas app defines the appropriate candidates for ALK testing, describes and compares several assay platforms for ALK testing, and discusses proposed screening-diagnosis paradigms for treatment with ALK inhibitors.

Visit the Apple iTunes app store or the Android Google Play Store from your mobine device to download the apps.

 

IASLC.org Site Search: "ALK Testing"

 

Other Resources:

www.alktesting.org - Here you will find useful information related to ALK and ALK testing, including key publications and relevant guidelines. New resources will be added as they become available.